These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 33878855)
21. Alopecia in patients with COVID-19: A systematic review and meta-analysis. Nguyen B; Tosti A JAAD Int; 2022 Jun; 7():67-77. PubMed ID: 35224518 [TBL] [Abstract][Full Text] [Related]
22. Safety and efficacy of ALRV5XR in men with androgenetic alopecia: A randomised, double-blinded, placebo-controlled clinical trial. Feldman PR; Fiebig KM; Piwko C; Mints BM; Brown D; Cahan DJ; Guevara-Aguirre J EClinicalMedicine; 2021 Oct; 40():101124. PubMed ID: 34541479 [TBL] [Abstract][Full Text] [Related]
23. Sex differences in clinical trials of ALRV5XR treatment of androgenetic alopecia and telogen effluvium. Feldman PR; Feldman OJ; Guevara-Aguirre J; Fiebig KM Front Med (Lausanne); 2022; 9():918058. PubMed ID: 36045927 [TBL] [Abstract][Full Text] [Related]
24. Trichobiolight: A new, effective protocol in the treatment of androgenetic alopecia and telogen effluvium. Piccolo D; Crisman G; Conforti C; Buzzi M; Genovesi C; Marchi D; Mazzaracchio D; Goldust M Dermatol Ther; 2021 Mar; 34(2):e14799. PubMed ID: 33486860 [TBL] [Abstract][Full Text] [Related]
26. Hair Shedding Evaluation for Alopecia: A Refined Wash Test. Li X; Wang X; Wang C; Zhang J; Zhou C Clin Cosmet Investig Dermatol; 2022; 15():117-126. PubMed ID: 35115799 [TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of topical finasteride spray solution for male androgenetic alopecia: a phase III, randomized, controlled clinical trial. Piraccini BM; Blume-Peytavi U; Scarci F; Jansat JM; Falqués M; Otero R; Tamarit ML; Galván J; Tebbs V; Massana E; J Eur Acad Dermatol Venereol; 2022 Feb; 36(2):286-294. PubMed ID: 34634163 [TBL] [Abstract][Full Text] [Related]
28. Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia. Price VH; Roberts JL; Hordinsky M; Olsen EA; Savin R; Bergfeld W; Fiedler V; Lucky A; Whiting DA; Pappas F; Culbertson J; Kotey P; Meehan A; Waldstreicher J J Am Acad Dermatol; 2000 Nov; 43(5 Pt 1):768-76. PubMed ID: 11050579 [TBL] [Abstract][Full Text] [Related]
29. Hair Regrowth with Novel Hemp Extract: A Case Series. Smith GL Int J Trichology; 2023; 15(1):18-24. PubMed ID: 37305187 [TBL] [Abstract][Full Text] [Related]
30. Analysis of Microscopic Examination of Pulled Out Hair in Telogen Effluvium Patients. Park SH; Seol JE; Kim DH; Kim H Ann Dermatol; 2020 Apr; 32(2):141-145. PubMed ID: 33911725 [TBL] [Abstract][Full Text] [Related]
31. Changes in hair weight in men with androgenetic alopecia after treatment with finasteride (1 mg daily): three- and 4-year results. Price VH; Menefee E; Sanchez M; Kaufman KD J Am Acad Dermatol; 2006 Jul; 55(1):71-4. PubMed ID: 16781295 [TBL] [Abstract][Full Text] [Related]
32. Natural scalp hair regression in preclinical stages of male androgenetic alopecia and its reversal by finasteride. Van Neste D Skin Pharmacol Physiol; 2006; 19(3):168-76. PubMed ID: 16679818 [TBL] [Abstract][Full Text] [Related]
33. Videodermatoscopy enhances diagnostic capability in some forms of hair loss. Lacarrubba F; Dall'Oglio F; Rita Nasca M; Micali G Am J Clin Dermatol; 2004; 5(3):205-8. PubMed ID: 15186200 [TBL] [Abstract][Full Text] [Related]
34. Changes in hair weight and hair count in men with androgenetic alopecia after treatment with finasteride, 1 mg, daily. Price VH; Menefee E; Sanchez M; Ruane P; Kaufman KD J Am Acad Dermatol; 2002 Apr; 46(4):517-23. PubMed ID: 11907500 [TBL] [Abstract][Full Text] [Related]
35. Histopathologic features of alopecia areata incognito: a review of 46 cases. Miteva M; Misciali C; Fanti PA; Tosti A J Cutan Pathol; 2012 Jun; 39(6):596-602. PubMed ID: 22616601 [TBL] [Abstract][Full Text] [Related]
36. A proprietary herbal extract against hair loss in androgenetic alopecia and telogen effluvium: a placebo-controlled, single-blind, clinical-instrumental study. Pekmezci E; Dündar C; Türkoğlu M Acta Dermatovenerol Alp Pannonica Adriat; 2018 Jun; 27(2):51-57. PubMed ID: 29945259 [TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of 3% minoxidil versus combined 3% minoxidil / 0.1% finasteride in male pattern hair loss: a randomized, double-blind, comparative study. Tanglertsampan C J Med Assoc Thai; 2012 Oct; 95(10):1312-6. PubMed ID: 23193746 [TBL] [Abstract][Full Text] [Related]
38. Adenosine increases anagen hair growth and thick hairs in Japanese women with female pattern hair loss: a pilot, double-blind, randomized, placebo-controlled trial. Oura H; Iino M; Nakazawa Y; Tajima M; Ideta R; Nakaya Y; Arase S; Kishimoto J J Dermatol; 2008 Dec; 35(12):763-7. PubMed ID: 19239555 [TBL] [Abstract][Full Text] [Related]